PHL HIV Conference Call Slides - The AIDS Institute · Title: PHL HIV Conference Call Slides...
Transcript of PHL HIV Conference Call Slides - The AIDS Institute · Title: PHL HIV Conference Call Slides...
HIV-1 Acute Infection Testing
(4th Generation) and
New Diagnostic Algorithms
Florida Consortium for HIV/AIDS Research
January 9, 2012
Berry Bennett, MPH Retrovirology Section Chief
FL. Bureau of Laboratories, FDOH [email protected]
Common HIV-1 or HIV-1/2 Diagnostic Algorithm
1989……………………….
Common HIV-1 or HIV-1/2 POC Rapid Test Algorithm
Challenges with the 1989 & 1998 Diagnostic
Algorithms
• Antibody tests do not detect infection in ~10% of infected
persons at highest risk of transmission1,2
• Western blot confirmation is less sensitive during early
infection than many widely used screening tests
• Assays were FDA approved as screening or supplemental
tests in the confirmatory process, not as part of “multi-test
algorithm”.
• WB and IFA supplemental assays cannot differentiate HIV-
1 from HIV-2 infections.
1) Patel, et.al. Arch Intern Med 2010; 170:66-74
2) Stekler et.al. Clin Infect Diseases 2009; 49:444-53
Detection of HIV by Diagnostic Tests
0 1 2 3 4 5 6 7 8 9 10
Symptoms
p24 Antigen
HIV RNA
HIV EIA*
Western blot
Weeks Since Infection
*3rd generation, IgM-sensitive EIA
Modified from After Fiebig et al,
AIDS 2003; 17(13):1871-9
*2nd generation EIA
*viral lysate EIA
*4th generation, Ag/Ab Combo EIA
Characteristics & Performance of 4th Generation
Immunoassays
• Simultaneous qualitative detection of HIV-1 p24 antigen and
antibodies to HIV-1 (Groups M and O) and HIV-2 in human serum or
plasma.
• Abbott Architect HIV Ag/Ab
Combo chemiluminescent
assay (CIA), June 2010.
PI sensitivity 100% (w/95% CI
of 94.31 - 100%).
PI specificity 99.77% (w/95% CI
of 99.62 – 99.88%)
• BioRad HIV Combo Ag/Ab EIA,
July 2011.
PI sensitivity 100% (w/95% CI
of 99.7 – 100%).
PI specificity 99.87% (w/95% CI
of 99.76 – 99.93%).
Process for Developing New HIV Testing
Algorithms for the U.S.
APHL/CDC HIV Steering Committee (2006)
Algorithm Workgroups [Point of contact (POC) and Laboratory] Goal = Develop multiple acceptable HIV testing algorithms, i.e., a menu of options
APHL & NASTAD Public Health Surveys
2007 HIV Diagnostics Conference (December 5-7, Atlanta)
Preparation of the Status Report, released April 2009 at www.aphl.org/hiv/statusreport
Status Report promotion at national conferences
2010 HIV Diagnostics Conference (March 24-26, Orlando)
Release of the CLSI Guidelines1, July 2011
CDC Dear Colleague letter to Surveillance Cordinators, Nov. 18, 2011
Each state must examine their case reporting and Ryan White eligibility criteria
Ongoing data gathering: retrospective and prospective
CDC Interim Guidance anticipated by mid-2012
2012 HIV Diagnostic Conference set for Dec. 12-14, 2012
Final CDC Recommendations to follow 1 Criteria for Laboratory Testing and Diagnosis of Human Immunodeficiency Virus Infection: Approved Guidelines. Clinical and Laboratory Standards Institute, M53-A.
CDC Dear Colleague Letter to Surveillance
Coordinators – Nov. 18, 2011
“Supplemental HIV antibody tests”
need not be limited to Western Blot
or IFA. Other antibody tests are
acceptable as supplemental tests,
including some that might
alternatively be used as initial
screening tests, provided that the
screening and supplemental tests
are used together as parts of an
algorithm.
Characteristics of the Proposed HIV
Diagnostic Algorithm
• Detect acute as well as established HIV
infections
• Differentiate HIV-1 from HIV-2
• Get timely results to facilitate initiation of care -
more same day reporting
• Eliminate indeterminate and inconclusive results
whenever possible
Proposed Laboratory Algorithm
Possible HIV-1/HIV-2 Differentiation
Immunoassays
Recombinant HIV-1 gp41
Peptide HIV-1 gp41 Peptide HIV-2 gp36
Serum Control
1 gp36
2 gp160
3 gp120
4 gp41
5 gp24
Proposed HIV Point of Care Algorithm 2
A1 [HIV-1 or HIV-1/2 rapid test (Blood or oral fluid)]
A2 [HIV-1 or HIV 1/2 rapid test from a
different manufacturer (blood)]
A1-
Negative for HIV-1
and HIV-2 antibodies*
A1+
A1+ A2+
Presumptive positive for
HIV-1 or HIV-2
antibodies; requires
medical follow-up for
further evaluation and
testing
A1+ A2-
Inconclusive rapid test
result;
requires additional testing
*If using an HIV-1 only rapid test, Negative for HIV-1 antibodies only
Two Rapid Tests (A1/A2) Performed in Sequence on Blood or Oral Fluid
(A1 and A2 must be different rapid tests)
Alternative Algorithms
• Individual or pooled NAAT on seronegative specimens (primarily reflex testing)
• Traditional algorithm with supplemental NAAT option
• Algorithms for oral fluid and dried fluid spot (DFS) specimens
• “Bridge algorithms” (POC – laboratory – clinical management)
HIV Testing Algorithm Information
• HIV Testing Algorithms: A Status Report (5/2009) http://www.aphl.org/hiv/statusreport
• 2010 HIV Diagnostics Conference: http://www.hivtestingconference.org
• CLSI M53-A, Criteria for Laboratory Testing and Diagnosis of HIV-1 Infection, 2011 (Includes algorithms utilizing assays available outside the US as well as those FDA approved)
• www.journalofclinicalvirology.com/inpress (supplement issue w/ focus on data related to the proposed HIV-1/2 diagnostic algorithm)
• Updated CDC recommendations anticipated early 2012.
Thank you & Questions??